Pradžia › Širdies ir kraujagyslių ligos › Kentukis
Širdies ir kraujagyslių ligos klinikiniai tyrimai Kentukis
15 tyrimai dėl Širdies ir kraujagyslių ligos ieško dalyvių vietose Kentukis.
Miestai Kentukis
Oficialus tyrimo tekstas (anglų kalba)
ELEVATE-HFpEF Clinical Study
- Norton Healthcare, Louisville
Renkami dalyviai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06678841EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Qualmedica Research - Bowling Green, Bowling Green
- The Research Group of Lexington, Lexington
- Research Integrity, LLC, Owensboro
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07064473Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Research Integrity, LLC, Owensboro
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT06909565Product Surveillance Registry
- Edgewood
- Louisville
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-09-18 · NCT01524276Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Bowling Green
- Clinical Trial Site, Lexington
- Clinical Trial Site, Versailles
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT07181109A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Clinical Research Site, Louisville
Renkami dalyviai3 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07816185Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- University of Kentucky, Lexington
- University of Louisville, Louisville
Renkami dalyviai
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-09-09 · NCT06310031Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- Louisville VA Medical Center, Louisville
Renkami dalyviai4 fazėLaukiami sveiki savanoriai
Amžius 75 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT04262206A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Bowling Green
- Research Site, Lexington
- Research Site, Lexington
- ir dar 4
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-24 · NCT07000357Cardiovascular Biorepository
- University of Kentucky, Department of Internal Medicine, Division of Cardiovascular Medicine, Lexington
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-24 · NCT00753974OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Graves Gilbert Clinic, Bowling Green
- Baptist Health Lexington, Lexington
- The Research Group of Lexington LLC, Lexington
Renkami dalyviai3 fazė
Amžius nuo 50 iki 105 · Visoms lytims · Atnaujinta 2026-08-21 · NCT07136012Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of Kentucky, Lexington
- Norton Hospital, Louisville
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-10 · NCT06526195Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
- University of Louisville, Louisville
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 30 iki 70 · Visoms lytims · Atnaujinta 2026-02-10 · NCT03670524Biopsy Collection and Repository Database
- University of Kentucky, Lexington
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-03 · NCT05521503Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
- University of Louisville, Louisville
Renkami dalyviai1/2 fazė
Amžius nuo 20 iki 85 · Visoms lytims · Atnaujinta 2024-12-12 · NCT06730828Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.